Yufei Xiang

2.2k citations
28 papers · 1.3k indexed · 1 hit paper · h-index 15
Topics
Monoclonal and Polyclonal Antibodies Research (11 papers)SARS-CoV-2 and COVID-19 Research (8 papers)Glycosylation and Glycoproteins Research (4 papers)
Partner nations
United StatesChinaIsrael

In The Last Decade

Yufei Xiang

27 papers receiving 1.3k citations

Hit Papers

Versatile and multivalent nanobodies efficiently neutrali...2020202620222024202050100150200250

Peers

Yufei Xiang
Comparison fields: 5 of 97
  • Molecular Biology 815
  • Infectious Diseases 397
  • Radiology, Nuclear Medicine and Imaging 383
  • Ecology 130
  • Genetics 129
Replace Brett D. Welch with:
Brett D. Welch United States
Yaroslav Tsybovsky United States
Frederico Aires‐da‐Silva Portugal
Debi P. Sarkar India
Gabriela Canziani United States
Theo Verrips Netherlands
Tomoko Hirama Canada
Weizao Chen United States
Gholamreza Hassanzadeh‐Ghassabeh Belgium
Patrick Lu United States
Yufei Xiang relative to Brett D. Welch United States Brett D. Welch's profile →
Citations per field
00.5×6.4×
Brett D. Welch · 1×
Citations per year

Countries citing papers authored by Yufei Xiang

Since Specialization
Citations

This map shows the geographic impact of Yufei Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Xiang more than expected).

Fields of papers citing papers by Yufei Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Xiang. The network helps show where Yufei Xiang may publish in the future.

Co-authorship network of co-authors of Yufei Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufei Xiang. A scholar is included among the top collaborators of Yufei Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufei Xiang. Yufei Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 1
3 11
4 3
5 38
6 18
7 7
8 102
9 34
10 22
11 12
12 33
13 36
14 34
15 66
16 23
17
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2breakdown →
265
18 8
19 132
20 74

About Yufei Xiang

Yufei Xiang is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Infectious Diseases (397 citations), Radiology, Nuclear Medicine and Imaging (383 citations) and Molecular Biology (815 citations). Yufei Xiang has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Yi Shi, Zhe Sang, Dina Schneidman‐Duhovny, Sham Nambulli, W. Paul Duprex, Cheng Zhang, Zhengyun Xiao, Kyonggeun Yoon, Bruce C. Byrne and William K. Holloman. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026